Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3260 of 6351
-
AI-Powered home exercise program aims to keep seniors on their feet
Prevention CompletedThe PRECISE study is a 12-week pilot intervention study to evaluate the usability of the new DigiPrehab technology application in elderly subjects. The DigiPrehab system will enable the early identification of seniors with significant risk factors for falling and will propose an …
Sponsor: Istituto Nazionale di Ricovero e Cura per Anziani • Aim: Prevention
Last updated Jun 26, 2026 15:20 UTC
-
New drug IBI343 takes on advanced cancers in first human trial
Disease control Recruiting nowThis is a Phase Ia/Ib, multicenter, open-label, first-in-human study to evaluate the safety, tolerability, PK, and efficacy of IBI343 in participants with locally advanced unresectable or metastatic solid tumors. It is planned to be carried out in different countries or regions s…
Phase 1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Knee pain showdown: PRP vs. hyaluronic acid – which injection works better?
Symptom relief Recruiting nowThe aim of the study is to compare the 12-month clinical outcomes of patients with patellofemoral osteoarthritis undergoing infiltrative treatment with fresh PRP and HA
Sponsor: Istituto Ortopedico Rizzoli • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
ALS drug safety check: oral edaravone passes extended trial
Disease control CompletedThe purpose of this study is to evaluate the safety of oral edaravone at a dose of 105 mg administered once daily for 10 days out of a 14-day period, followed by a 14-day drug-free period. This study will be continued until the earlier date when oral edaravone is commercially ava…
Phase 3 • Sponsor: Shionogi • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug combo takes on advanced cancers in early trial
Disease control OngoingThe purpose of this study is to characterize the safety and tolerability of KFA115 and KFA115 in combination with pembrolizumab in patients with select advanced cancers, and to identify the maximum tolerated dose and/or recommended dose.
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Sweat away the blues: exercise may speed bipolar depression recovery
Symptom relief PausedHypothesis: the hypothesis of the study is that aerobic physical exercise (PE) performed with the method Braining accelerates recovery from bipolar depression as well as improves psychiatric and somatic health in individuals with bipolar depression Method: a randomized controlled…
Sponsor: Region Stockholm • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Can a 5-Session program lift mood? large study tests community mental health help
Symptom relief CompletedThe goal is to improve mental health. The study will evaluate the impact of community-based mental health services. Successful completion of this study will contribute to the National Institute of Mental Health Strategic Plan employing implementation science to maximize the publi…
Sponsor: George Washington University • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Pumping iron against cancer: exercise may protect muscle during chemo
Symptom relief CompletedThis study evaluates the effectiveness of a supervised progressive resistance training program in patients malignant lymphomas with the primary outcome being lean body mass. The study is designed as a a single center, two-armed, parallel-group, investigator-initiated clinical ra…
Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Can mirror therapy and brain beats help stroke survivors walk again?
Symptom relief Recruiting nowThis study aims to compare the effects of mirror therapy combined with either neuromuscular electrical stimulation or binaural beat stimulation on post-stroke lower limb motor function recovery. The study also explores the relationship between patients' cortical excitability and …
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 13:44 UTC
-
Zapping the brain to unlock lost words: a new hope for stroke survivors?
Symptom relief CompletedHigh-Definition Transcranial Direct Current Stimulation (HD-tDCS) allows to induce, in a non-invasive way, a transient inhibitory or excitatory neuromodulation of a given cerebral region and to obtain a very focused cortical effect. Previous studies using HD-tDCS have shown the e…
Sponsor: Adrian Guggisberg • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Could your own belly fat fix a painful hip?
Symptom relief CompletedThe aim of the study is to evaluate the safety and efficacy up to 12 months of MF-AT in the echo-guided infiltrative treatment of hip OA through clinical, subjective and objective evaluations.
Sponsor: Istituto Ortopedico Rizzoli • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Blood test may guide diet to treat esophagitis
Disease control CompletedThis is a randomized, double blind, sham-controlled, pilot/feasibility trial of individualized dietary elimination treatment.
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Yoga for the mind: VA tests ancient practice to boost Veterans' daily functioning
Symptom relief Recruiting nowThis is a hybrid1, effectiveness-implementation study of yoga-based exercises (YE) as an adjunctive tool for rehabilitation among persons with Severe Mental Illness (SMI). The two-arm randomized controlled trial will compare the efficacy of YE compared to the Wellness Lifestyle P…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could a headband zap away dialysis pain?
Symptom relief OngoingThis is a 4-year project to see if a small battery-powered, device attached to a headband, that sits on the skin surface and delivers what is a hardly noticeable level of electrical stimulation can reduce pain in patients who receive hemodialysis on an ongoing basis.
Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New cancer drug GEN1056 tested in first human trial
Disease control CompletedThe main purpose of this first-in-human study of GEN1056, is to evaluate safety. In addition, the study will determine the recommended dose and frequency for subsequent clinical studies and will assess the preliminary anti-tumor activity of GEN1056. GEN1056 will be studied in pat…
Phase 1 • Sponsor: Genmab • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a drug for addiction help restless legs sufferers?
Symptom relief PausedProof of concept, double-blind, randomized, placebo-controlled trial with d-methadone proposed for the first time for use in the treatment of patients diagnosed with primary, moderate to very severe Restless Legs Syndrome (RLS). Its glutamatergic mechanism of action might be effe…
Phase 2 • Sponsor: Mauro Manconi • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New training aims to ease burden on brain tumor caregivers
Symptom relief OngoingFamily caregivers of patients with a primary brain tumor experience a high caregiving load including assistance with activities of daily living without any formal training. It is not surprising that this vulnerable caregiver population reports high levels of distress along with n…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Bladder gel shows promise for chronic pelvic pain in women
Symptom relief CompletedThis study will be conducted with the aim of ensuring the continued acceptability of the benefit-risk ratio and confirming the safety and performance of the device throughout its expected lifetime. Cystistat is supplied as a 50 mL solution containing 40 mg of sodium hyaluronate. …
Sponsor: MEDA Pharma GmbH & Co. KG • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Veteran peers lead fight against opioid overdose
Knowledge-focused OngoingMilitary veterans in the U.S. represent one of the populations most disproportionately impacted by the current opioid crisis. Veterans who use opioids and are not connected to the VA healthcare system have high rates of homelessness and experience higher prevalence of comorbid su…
Sponsor: New York University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
New cancer drug enzelkitug enters first human trials
Disease control OngoingThis is a first-in-human study to evaluate the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of enzelkitug when administered as a single agent and in combination with atezolizumab or pembrolizumab in adult participants with locally advanced or metastatic so…
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC